CN Stock MarketDetailed Quotes

600351 Yabao Pharmaceutical Group

Watchlist
  • 5.25
  • -0.02-0.38%
Not Open Sep 13 15:00 CST
3.78BMarket Cap17.86P/E (TTM)

Yabao Pharmaceutical Group Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-5.82%1.44B
-3.66%771.21M
7.05%2.91B
11.49%2.2B
18.46%1.53B
15.30%800.5M
-1.66%2.72B
-10.56%1.97B
-11.67%1.29B
-12.47%694.3M
Operating revenue
-5.82%1.44B
-3.66%771.21M
7.05%2.91B
11.49%2.2B
18.46%1.53B
15.30%800.5M
-1.66%2.72B
-10.56%1.97B
-11.67%1.29B
-12.47%694.3M
Other operating revenue
-32.37%13.72M
----
-21.34%29.46M
----
14.62%20.29M
----
-54.99%37.45M
----
-65.23%17.7M
----
Total operating cost
-7.44%1.25B
-4.76%644.62M
3.20%2.62B
6.14%1.97B
14.29%1.35B
12.58%676.85M
-1.81%2.54B
-9.33%1.86B
-13.50%1.18B
-17.01%601.22M
Operating cost
0.69%659.98M
1.68%336.34M
2.25%1.23B
9.59%948.86M
16.34%655.43M
18.18%330.78M
11.35%1.2B
-1.77%865.83M
-0.38%563.39M
-10.67%279.89M
Operating tax surcharges
-4.53%18.4M
2.25%10.06M
3.91%35.29M
9.50%27.76M
14.00%19.28M
8.89%9.84M
1.72%33.96M
-4.39%25.35M
-8.90%16.91M
-11.04%9.03M
Operating expense
-23.53%371.48M
-15.97%200.64M
8.27%971.69M
5.03%710.76M
16.01%485.79M
6.97%238.76M
-13.98%897.47M
-17.26%676.73M
-24.88%418.76M
-23.71%223.2M
Administration expense
-2.42%127.51M
-1.79%66.75M
-0.50%265.91M
3.37%198.58M
4.39%130.67M
13.98%67.97M
2.58%267.25M
-2.71%192.1M
-8.10%125.17M
-9.69%59.63M
Financial expense
-96.37%129.01K
-108.05%-181.24K
-70.23%3.22M
-56.71%3.72M
-38.81%3.55M
-41.93%2.25M
-26.65%10.83M
-38.04%8.59M
-46.47%5.8M
-45.16%3.88M
-Interest expense (Financial expense)
-56.78%3.62M
-55.33%1.83M
-34.47%12.3M
-23.79%10.73M
-11.19%8.37M
-9.31%4.11M
-16.98%18.77M
-16.19%14.09M
-13.63%9.42M
-28.83%4.53M
-Interest Income (Financial expense)
27.30%-3.63M
-1.35%-2.06M
-16.01%-9.49M
-33.87%-7.3M
-28.19%-4.99M
-183.87%-2.03M
3.76%-8.18M
-32.75%-5.46M
-277.76%-3.89M
-21.62%-715.82K
Research and development
33.02%68.9M
13.75%31.01M
-9.44%118.29M
-7.59%84.57M
7.64%51.8M
6.53%27.26M
-16.87%130.62M
-20.06%91.52M
-34.44%48.12M
-27.61%25.59M
Credit Impairment Loss
71.75%-1.23M
-58.44%-835.84K
125.77%2.07M
188.91%1.79M
43.37%-4.35M
92.02%-527.53K
-176.15%-8.04M
-72.95%619.92K
-1,637.38%-7.68M
25.15%-6.61M
Asset Impairment Loss
-338.99%-5.99M
65.53%-235.38K
-37.75%-93.75M
-507.01%-1.09M
29.48%-1.36M
-722.91%-682.93K
-114.92%-68.06M
103.60%267.69K
36.12%-1.93M
46.98%-82.99K
Other net revenue
173.79%14.86M
50.94%10.34M
-13.78%-62.69M
27.08%20.1M
24.77%5.43M
231.10%6.85M
-316.22%-55.09M
-8.44%15.81M
-54.52%4.35M
-174.15%-5.23M
Fair value change income
131.57%33.79K
98.54%-6.74K
27.09%-2.58M
97.63%-2.23K
-110.90%-107.04K
-420.48%-460.67K
-365.20%-3.54M
-26.63%-94.45K
6,777.60%981.67K
-14,346.63%-88.51K
Invest income
108.77%135.32K
153.57%223.75K
-337.80%-2.76M
-146.38%-2.12M
-126.74%-1.54M
53.54%-417.64K
-104.66%-631.22K
3,167.03%4.58M
94.63%5.77M
-138.42%-898.99K
-Including: Investment income associates
37.33%-129.49K
-1.41%-99.84K
-9.63%-411.63K
1.07%-302.27K
-1.45%-206.64K
-139.37%-98.45K
78.92%-375.45K
94.70%-305.54K
93.62%-203.69K
97.36%-41.13K
Asset deal income
-94.04%56.38K
-100.00%44.28
866.42%1.12M
2,468.09%970.33K
1,653.44%946.18K
50,795.48%905.47K
-22.06%116.09K
-77.35%37.78K
924.37%53.96K
-120.93%-1.79K
Other revenue
84.46%21.85M
39.34%11.19M
32.53%33.21M
97.46%20.55M
65.31%11.85M
226.50%8.03M
-20.62%25.06M
-53.10%10.41M
-21.59%7.17M
-48.07%2.46M
Operating profit
10.64%212.14M
4.94%136.94M
83.20%226.34M
91.05%245.29M
59.63%191.74M
48.55%130.5M
-39.20%123.55M
-25.06%128.39M
6.85%120.12M
31.47%87.85M
Add:Non operating Income
62.33%1.03M
253.23%570.04K
-48.43%2.95M
-52.05%1.16M
-51.32%635.69K
-57.90%161.38K
-6.78%5.73M
37.71%2.41M
111.55%1.31M
453.37%383.33K
Less:Non operating expense
-58.99%367.4K
-82.68%120.92K
184.04%10.31M
-49.72%1.64M
-59.90%895.89K
-54.32%698.09K
-53.29%3.63M
-52.33%3.26M
70.92%2.23M
242.92%1.53M
Total profit
11.14%212.81M
5.72%137.39M
74.28%218.98M
91.93%244.81M
60.66%191.48M
49.89%129.96M
-37.67%125.65M
-23.28%127.55M
6.68%119.19M
30.49%86.7M
Less:Income tax cost
51.11%37.61M
28.86%27.62M
85.65%39.07M
59.91%32.31M
19.37%24.89M
28.63%21.43M
18.02%21.04M
-4.65%20.21M
47.15%20.85M
495.63%16.66M
Net profit
5.16%175.19M
1.14%109.77M
71.99%179.91M
97.96%212.5M
69.41%166.59M
54.95%108.53M
-43.08%104.6M
-26.00%107.34M
0.80%98.34M
10.05%70.04M
Net profit from continuing operation
5.16%175.19M
1.14%109.77M
71.99%179.91M
97.96%212.5M
69.41%166.59M
54.95%108.53M
-43.08%104.6M
-26.00%107.34M
0.80%98.34M
10.05%70.04M
Less:Minority Profit
-219.32%-4.58M
-324.59%-2.49M
-38,649.35%-19.67M
-364.65%-1.31M
30.51%-1.44M
182.59%1.11M
98.47%-50.77K
332.56%496.67K
-16.91%-2.07M
-23.62%-1.34M
Net profit of parent company owners
6.99%179.77M
4.51%112.26M
90.71%199.59M
100.11%213.82M
67.35%168.03M
50.47%107.42M
-44.06%104.66M
-26.45%106.85M
1.08%100.4M
10.28%71.39M
Earning per share
Basic earning per share
13.29%0.2472
9.53%0.1528
85.71%0.26
101.15%0.2792
67.33%0.2182
50.49%0.1395
-41.67%0.14
-26.44%0.1388
1.09%0.1304
10.23%0.0927
Diluted earning per share
----
9.53%0.1528
----
101.15%0.2792
----
50.49%0.1395
----
-26.44%0.1388
1.09%0.1304
10.23%0.0927
Other composite income
-10,199.39%-4.4M
-159.01%-97.31K
-105.02%-3.9K
-362.16%-14.27K
221.11%43.59K
1,553.48%164.91K
582.34%77.65K
607.58%5.44K
Other composite income of parent company owners
----
----
-10,199.39%-4.4M
-159.01%-97.31K
-105.02%-3.9K
-362.16%-14.27K
221.11%43.59K
1,553.48%164.91K
582.34%77.65K
607.58%5.44K
Total composite income
5.16%175.19M
1.16%109.77M
67.72%175.51M
97.57%212.4M
69.27%166.59M
54.91%108.52M
-43.04%104.65M
-25.88%107.51M
0.89%98.41M
10.06%70.05M
Total composite income of parent company owners
6.99%179.77M
4.52%112.26M
86.42%195.18M
99.71%213.72M
67.22%168.02M
50.44%107.41M
-44.03%104.7M
-26.33%107.01M
1.18%100.48M
10.29%71.39M
Total composite income of minority owners
-219.32%-4.58M
-324.59%-2.49M
-38,649.35%-19.67M
-364.65%-1.31M
30.51%-1.44M
182.59%1.11M
98.47%-50.77K
332.56%496.67K
-16.91%-2.07M
-23.62%-1.34M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -5.82%1.44B-3.66%771.21M7.05%2.91B11.49%2.2B18.46%1.53B15.30%800.5M-1.66%2.72B-10.56%1.97B-11.67%1.29B-12.47%694.3M
Operating revenue -5.82%1.44B-3.66%771.21M7.05%2.91B11.49%2.2B18.46%1.53B15.30%800.5M-1.66%2.72B-10.56%1.97B-11.67%1.29B-12.47%694.3M
Other operating revenue -32.37%13.72M-----21.34%29.46M----14.62%20.29M-----54.99%37.45M-----65.23%17.7M----
Total operating cost -7.44%1.25B-4.76%644.62M3.20%2.62B6.14%1.97B14.29%1.35B12.58%676.85M-1.81%2.54B-9.33%1.86B-13.50%1.18B-17.01%601.22M
Operating cost 0.69%659.98M1.68%336.34M2.25%1.23B9.59%948.86M16.34%655.43M18.18%330.78M11.35%1.2B-1.77%865.83M-0.38%563.39M-10.67%279.89M
Operating tax surcharges -4.53%18.4M2.25%10.06M3.91%35.29M9.50%27.76M14.00%19.28M8.89%9.84M1.72%33.96M-4.39%25.35M-8.90%16.91M-11.04%9.03M
Operating expense -23.53%371.48M-15.97%200.64M8.27%971.69M5.03%710.76M16.01%485.79M6.97%238.76M-13.98%897.47M-17.26%676.73M-24.88%418.76M-23.71%223.2M
Administration expense -2.42%127.51M-1.79%66.75M-0.50%265.91M3.37%198.58M4.39%130.67M13.98%67.97M2.58%267.25M-2.71%192.1M-8.10%125.17M-9.69%59.63M
Financial expense -96.37%129.01K-108.05%-181.24K-70.23%3.22M-56.71%3.72M-38.81%3.55M-41.93%2.25M-26.65%10.83M-38.04%8.59M-46.47%5.8M-45.16%3.88M
-Interest expense (Financial expense) -56.78%3.62M-55.33%1.83M-34.47%12.3M-23.79%10.73M-11.19%8.37M-9.31%4.11M-16.98%18.77M-16.19%14.09M-13.63%9.42M-28.83%4.53M
-Interest Income (Financial expense) 27.30%-3.63M-1.35%-2.06M-16.01%-9.49M-33.87%-7.3M-28.19%-4.99M-183.87%-2.03M3.76%-8.18M-32.75%-5.46M-277.76%-3.89M-21.62%-715.82K
Research and development 33.02%68.9M13.75%31.01M-9.44%118.29M-7.59%84.57M7.64%51.8M6.53%27.26M-16.87%130.62M-20.06%91.52M-34.44%48.12M-27.61%25.59M
Credit Impairment Loss 71.75%-1.23M-58.44%-835.84K125.77%2.07M188.91%1.79M43.37%-4.35M92.02%-527.53K-176.15%-8.04M-72.95%619.92K-1,637.38%-7.68M25.15%-6.61M
Asset Impairment Loss -338.99%-5.99M65.53%-235.38K-37.75%-93.75M-507.01%-1.09M29.48%-1.36M-722.91%-682.93K-114.92%-68.06M103.60%267.69K36.12%-1.93M46.98%-82.99K
Other net revenue 173.79%14.86M50.94%10.34M-13.78%-62.69M27.08%20.1M24.77%5.43M231.10%6.85M-316.22%-55.09M-8.44%15.81M-54.52%4.35M-174.15%-5.23M
Fair value change income 131.57%33.79K98.54%-6.74K27.09%-2.58M97.63%-2.23K-110.90%-107.04K-420.48%-460.67K-365.20%-3.54M-26.63%-94.45K6,777.60%981.67K-14,346.63%-88.51K
Invest income 108.77%135.32K153.57%223.75K-337.80%-2.76M-146.38%-2.12M-126.74%-1.54M53.54%-417.64K-104.66%-631.22K3,167.03%4.58M94.63%5.77M-138.42%-898.99K
-Including: Investment income associates 37.33%-129.49K-1.41%-99.84K-9.63%-411.63K1.07%-302.27K-1.45%-206.64K-139.37%-98.45K78.92%-375.45K94.70%-305.54K93.62%-203.69K97.36%-41.13K
Asset deal income -94.04%56.38K-100.00%44.28866.42%1.12M2,468.09%970.33K1,653.44%946.18K50,795.48%905.47K-22.06%116.09K-77.35%37.78K924.37%53.96K-120.93%-1.79K
Other revenue 84.46%21.85M39.34%11.19M32.53%33.21M97.46%20.55M65.31%11.85M226.50%8.03M-20.62%25.06M-53.10%10.41M-21.59%7.17M-48.07%2.46M
Operating profit 10.64%212.14M4.94%136.94M83.20%226.34M91.05%245.29M59.63%191.74M48.55%130.5M-39.20%123.55M-25.06%128.39M6.85%120.12M31.47%87.85M
Add:Non operating Income 62.33%1.03M253.23%570.04K-48.43%2.95M-52.05%1.16M-51.32%635.69K-57.90%161.38K-6.78%5.73M37.71%2.41M111.55%1.31M453.37%383.33K
Less:Non operating expense -58.99%367.4K-82.68%120.92K184.04%10.31M-49.72%1.64M-59.90%895.89K-54.32%698.09K-53.29%3.63M-52.33%3.26M70.92%2.23M242.92%1.53M
Total profit 11.14%212.81M5.72%137.39M74.28%218.98M91.93%244.81M60.66%191.48M49.89%129.96M-37.67%125.65M-23.28%127.55M6.68%119.19M30.49%86.7M
Less:Income tax cost 51.11%37.61M28.86%27.62M85.65%39.07M59.91%32.31M19.37%24.89M28.63%21.43M18.02%21.04M-4.65%20.21M47.15%20.85M495.63%16.66M
Net profit 5.16%175.19M1.14%109.77M71.99%179.91M97.96%212.5M69.41%166.59M54.95%108.53M-43.08%104.6M-26.00%107.34M0.80%98.34M10.05%70.04M
Net profit from continuing operation 5.16%175.19M1.14%109.77M71.99%179.91M97.96%212.5M69.41%166.59M54.95%108.53M-43.08%104.6M-26.00%107.34M0.80%98.34M10.05%70.04M
Less:Minority Profit -219.32%-4.58M-324.59%-2.49M-38,649.35%-19.67M-364.65%-1.31M30.51%-1.44M182.59%1.11M98.47%-50.77K332.56%496.67K-16.91%-2.07M-23.62%-1.34M
Net profit of parent company owners 6.99%179.77M4.51%112.26M90.71%199.59M100.11%213.82M67.35%168.03M50.47%107.42M-44.06%104.66M-26.45%106.85M1.08%100.4M10.28%71.39M
Earning per share
Basic earning per share 13.29%0.24729.53%0.152885.71%0.26101.15%0.279267.33%0.218250.49%0.1395-41.67%0.14-26.44%0.13881.09%0.130410.23%0.0927
Diluted earning per share ----9.53%0.1528----101.15%0.2792----50.49%0.1395-----26.44%0.13881.09%0.130410.23%0.0927
Other composite income -10,199.39%-4.4M-159.01%-97.31K-105.02%-3.9K-362.16%-14.27K221.11%43.59K1,553.48%164.91K582.34%77.65K607.58%5.44K
Other composite income of parent company owners ---------10,199.39%-4.4M-159.01%-97.31K-105.02%-3.9K-362.16%-14.27K221.11%43.59K1,553.48%164.91K582.34%77.65K607.58%5.44K
Total composite income 5.16%175.19M1.16%109.77M67.72%175.51M97.57%212.4M69.27%166.59M54.91%108.52M-43.04%104.65M-25.88%107.51M0.89%98.41M10.06%70.05M
Total composite income of parent company owners 6.99%179.77M4.52%112.26M86.42%195.18M99.71%213.72M67.22%168.02M50.44%107.41M-44.03%104.7M-26.33%107.01M1.18%100.48M10.29%71.39M
Total composite income of minority owners -219.32%-4.58M-324.59%-2.49M-38,649.35%-19.67M-364.65%-1.31M30.51%-1.44M182.59%1.11M98.47%-50.77K332.56%496.67K-16.91%-2.07M-23.62%-1.34M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data